Heard of SDSE? This under-recognised strep bacterium is causing a growing number of serious infections in Australia, with First Nations Australians disproportionately affected.
Learn more ๐ https://bit.ly/3KDYy6r
@thedohertyinst.bsky.social
The Peter Doherty Institute for Infection and Immunity is a joint-venture between The University of Melbourne and The Royal Melbourne Hospital. Research includes #HIV, #hepatitis, #malaria, #influenza #COVID19 & more. www.doherty.edu.au
Heard of SDSE? This under-recognised strep bacterium is causing a growing number of serious infections in Australia, with First Nations Australians disproportionately affected.
Learn more ๐ https://bit.ly/3KDYy6r
Behind the scenes of the Australian Institute for Infectious Disease build. An exciting milestone to see demolition close to completion, paving the way for construction on the state-of-the-art research facility.
Learn more ๐ https://bit.ly/4no192U
@burnetinstitute.bsky.social @unimelb.bsky.social
New data released in The Viral Hepatitis Mapping Project: National Report shows Aus is more than 10 years behind meeting national targets, highlighting areas for intervention to improve treatment and care of chronic hepatitis B.
www.doherty.edu.au/news-events/...
A new survey explores community views on outbreak research. Understanding community needs is essential for an effective early response to future outbreaks. Victorians can help protect their communities by participating in the survey!
www.doherty.edu.au/news-events/...
This event will be a landmark moment in the global fight against hepatitis. We're excited to share our expertise through the WHO Collaborating Centre for Viral Hepatitis, one of five centres globally, based here at the Doherty Institute! www.doherty.edu.au/news-events/...
01.04.2025 01:14 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0A new approach led by Professor Lachlan Coin, PhD Candidate Daniel Rawlinson and a team of researchers identifies key features for predicting disease using complex biological data - enabling low-cost point-of-care tests for cancers and infectious diseases. ๐งฌ
www.doherty.edu.au/news-events/...
Congratulations Professor Laura Mackay, recipient of the Elizabeth Blackburn Investigator Grant Award ๐ Her exciting work with tissue-resident memory T cells (TRM) could lead to innovative new immunotherapies that improve global health outcomes.
www.doherty.edu.au/news-events/...
The world was close to eliminating HIV as a public health threatโโwithin five yearsโ says Professor Sharon Lewin. Now there is a risk of dramatic increases in infections, death and a real loss of decades of advances.
www.theguardian.com/global-devel...
Through the Australia Awards Fellowship, the Centre for Pathogen Genomics recently hosted 11 public health professionals from the Asia-Pacific for an intensive five-week training program in genomics-informed surveillance and diagnosis of infectious diseases.
www.doherty.edu.au/news-events/...
In a recent study published in Science Advances, the University of Melbourne's @carissaaurelia.bsky.social, PhD Candidate in the Chung Lab highlights the importance of COVID-19 boosters, especially for those with a weaker immune system. go.unimelb.edu.au/5rxp
18.03.2025 23:00 โ ๐ 1 ๐ 0 ๐ฌ 0 ๐ 0Professor Peter Doherty standing in front of the Peter Doherty Institute for Infection and Immunity building in Melbourne.
Laureate Professor @pcdoherty.bsky.social speaks about the state of public discourse, attitudes towards public health today, how we best prepare for the next pandemic and the still great potential in medical research. Read the full story, originally published by 360info go.unimelb.edu.au/ez6p
17.03.2025 22:40 โ ๐ 2 ๐ 1 ๐ฌ 0 ๐ 0Led by Professor Damian Purcell a $4.3 million grant under the Adopting Sustainable Partnerships for Innovative Research Ecosystem program will support the development of RNA and small molecule therapies to treat HTLV infections which affect around 10 million people globally.
go.unimelb.edu.au/7cnp